1. Drug-induced torsades de pointes and implications for drug development;Fenichel;J Cardiovasc Electrophysiol,2004
2. Role of delayed rectifier potassium channels in cardiac repolarisation and arrhythmias;Sanguinetti;News Physiol Sci,1997
3. 5 US Food and Drug Administration [Internet]. ICH S7B Guideline. Step 2 Revision. The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. 2004. Available at: http://www.fda.gov/cder/guidance/5533dft.htm (accessed November 20, 2008).